Federal appeals court keeps abortion pill available temporarily. However, the ruling blocks getting mifepristone through the mail and rolls back other steps the government had taken to improve access. Read more
THURSDAY, April 13, 2023 (HealthDay News) — A federal appeals court on Wednesday said the abortion pill mifepristone could remain available for now. But the court’s judges added some provisions to their ruling: A block on mailing the pill to patients as well as stays on other measures the federal government has taken recently to boost access to the medication.
New drug may treat rare diseases that make sunlight exposure painful. Known as “shadow jumpers,” these patients experience excruciating pain after just a short time in the sun. But a new pill helped their bodies produce more protective pigmentation. Read more
THURSDAY, April 13, 2023 (HealthDay News) — It sounds like the stuff of a vampire novel, but for people with a group of rare genetic disorders, exposure to sunlight can cause excruciating pain.
Blood donor’s gender won’t affect outcomes for recipient. Researchers concluded this after studying more than 8,700 patients. Read more
People are also reading…
THURSDAY, April 13, 2023 (HealthDay News) — Whether the gender of a blood donor could affect the recipient’s survival was an unanswered question in medicine. Until now.
Juul settles lawsuits from numerous states for $462 million. The e-cigarette maker settled Wednesday with New York, California, Colorado, the District of Columbia, Illinois, Massachusetts and New Mexico. Read more
THURSDAY, April 13, 2023 (HealthDay News) – Juul Labs on Wednesday reached a $462 million settlement with several states over the aggressive marketing of its electronic cigarettes to minors.
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.
Denial of responsibility! NewsBit.us is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
